Publications by authors named "S Pescariu"
Cardiovascular diseases (CVDs) constitute a significant cause of morbidity and mortality globally, particularly among individuals with type 2 diabetes mellitus (T2DM). Ertugliflozin, a Sodium-Glucose Co-transporter-2 (SGLT2) inhibitor, is hypothesized to confer cardiovascular protection; however, long-term follow-up studies are necessary to support the hypothesis. This systematic review was conducted to evaluate the cardiovascular effects of ertugliflozin in diabetic versus non-diabetic cohorts, focusing on major adverse cardiovascular events (MACEs), hospitalizations for heart failure, and cardiovascular mortality.
View Article and Find Full Text PDFArticle Synopsis
- * A study at "Victor Babes" Hospital included 180 patients, revealing that those with both CHF and COPD experienced the greatest HRQoL deterioration, reflected in longer hospital stays and lower initial oxygen saturation levels.
- * Notably, significant improvements in HRQoL were observed three months after discharge across all groups, highlighting the importance of targeted recovery programs that cater to the complications arising from the coexistence of these chronic conditions. *
Lipomatous hypertrophy of the interatrial septum (LHIAS) represents a benign proliferation of lipoid cells at the level of the interatrial septum (IAS) inducing an important thickening of this structure. It respects the fossa ovalis (FO) region, having a typical "hourglass" echocardiographic appearance. There are certain cases though, with unusual appearances and/or with associated pathologies that may induce similar lesions in the heart, in which the differential diagnosis cannot be guaranteed using only the standard methods.
View Article and Find Full Text PDFUtility of Kansas City Cardiomyopathy Questionnaire (KCCQ) in Assessing Quality of Life among Patients with Heart Failure Undergoing Exercise Training Rehabilitation: A Systematic Review.
Diseases
March 2024
This systematic review evaluates the effectiveness of the Kansas City Cardiomyopathy Questionnaire (KCCQ) in assessing quality of life improvements among patients with heart failure (HF) undergoing various forms of exercise training rehabilitation, including telemedicine and in-person modalities, across all stages of HF, irrespective of ejection fraction (EF) and clinical status. The aim was to collate evidence from studies employing the KCCQ as a measure of quality of life (QoL). A comprehensive search strategy was implemented across PubMed, Scopus, and Embase databases, adhering to the PRISMA guidelines, including literature up until October 2023.
View Article and Find Full Text PDFArticle Synopsis
- Patients with NYHA class I and II heart failure face significant morbidity and mortality, prompting an investigation of a new tissue Doppler index, E/(e' × s'), for predicting long-term cardiac events.
- A study involving 212 hospitalized heart failure patients monitored cardiac events over three months, revealing that nearly half experienced events such as cardiac death or rehospitalization.
- The E/(e' × s') > 1.6 at discharge was identified as a strong independent predictor of adverse outcomes, particularly when patients showed further deterioration after three months.